Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Similar articles for PubMed (Select 22634226)

1.

Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia.

Xie Y, Su N, Jin M, Qi H, Yang J, Li C, Du X, Luo F, Chen B, Shen Y, Huang H, Xian CJ, Deng C, Chen L.

Hum Mol Genet. 2012 Sep 15;21(18):3941-55. doi: 10.1093/hmg/dds181. Epub 2012 May 24.

2.

PTH has the potential to rescue disturbed bone growth in achondroplasia.

Ueda K, Yamanaka Y, Harada D, Yamagami E, Tanaka H, Seino Y.

Bone. 2007 Jul;41(1):13-8. Epub 2007 Mar 12.

PMID:
17466614
3.

Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.

Yamashita A, Morioka M, Kishi H, Kimura T, Yahara Y, Okada M, Fujita K, Sawai H, Ikegawa S, Tsumaki N.

Nature. 2014 Sep 25;513(7519):507-11. doi: 10.1038/nature13775. Epub 2014 Sep 17.

4.
5.

PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.

Yamanaka Y, Tanaka H, Koike M, Nishimura R, Seino Y.

J Bone Miner Res. 2003 Aug;18(8):1395-403.

PMID:
12929929
6.

A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.

Jin M, Yu Y, Qi H, Xie Y, Su N, Wang X, Tan Q, Luo F, Zhu Y, Wang Q, Du X, Xian CJ, Liu P, Huang H, Shen Y, Deng CX, Chen D, Chen L.

Hum Mol Genet. 2012 Dec 15;21(26):5443-55. doi: 10.1093/hmg/dds390. Epub 2012 Sep 26.

7.

FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.

Matsushita T, Wilcox WR, Chan YY, Kawanami A, Bükülmez H, Balmes G, Krejci P, Mekikian PB, Otani K, Yamaura I, Warman ML, Givol D, Murakami S.

Hum Mol Genet. 2009 Jan 15;18(2):227-40. doi: 10.1093/hmg/ddn339. Epub 2008 Oct 15.

8.
9.

Molecular basis for the treatment of achondroplasia.

Yamanaka Y, Ueda K, Seino Y, Tanaka H.

Horm Res. 2003;60 Suppl 3:60-4.

PMID:
14671399
10.

Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene.

Matsushita M, Hasegawa S, Kitoh H, Mori K, Ohkawara B, Yasoda A, Masuda A, Ishiguro N, Ohno K.

Endocrinology. 2015 Feb;156(2):548-54. doi: 10.1210/en.2014-1914. Epub 2014 Dec 2.

PMID:
25456072
11.

Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.

Bonaventure J, Rousseau F, Legeai-Mallet L, Le Merrer M, Munnich A, Maroteaux P.

Am J Med Genet. 1996 May 3;63(1):148-54.

PMID:
8723101
12.
13.

Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.

Iwata T, Li CL, Deng CX, Francomano CA.

Hum Mol Genet. 2001 Jun 1;10(12):1255-64.

14.

Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.

Pannier S, Mugniery E, Jonquoy A, Benoist-Lasselin C, Odent T, Jais JP, Munnich A, Legeai-Mallet L.

Bone. 2010 Nov;47(5):905-15. doi: 10.1016/j.bone.2010.07.020. Epub 2010 Jul 29.

PMID:
20673820
15.
16.

FGFR3 mutation causes abnormal membranous ossification in achondroplasia.

Di Rocco F, Biosse Duplan M, Heuzé Y, Kaci N, Komla-Ebri D, Munnich A, Mugniery E, Benoist-Lasselin C, Legeai-Mallet L.

Hum Mol Genet. 2014 Jun 1;23(11):2914-25. doi: 10.1093/hmg/ddu004. Epub 2014 Jan 12.

17.
18.

Reduced binding of FGF1 to mutant fibroblast growth factor receptor 3.

Khnykin D, Olsnes S.

Growth Factors. 2006 Jun;24(2):111-9.

PMID:
16801131
19.

Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.

Camera G, Baldi M, Strisciuglio G, Concolino D, Mastroiacovo P, Baffico M.

Am J Med Genet. 2001 Dec 15;104(4):277-81. Erratum in: Am J Med Genet 2002 Jun 15;110(2):193.

PMID:
11754059
20.

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.

Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA, Fu XY.

Nature. 1997 Mar 20;386(6622):288-92.

PMID:
9069288
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk